SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Muhammad Ali — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMuhammad Ali
Date of birth1942-01-17
IdentifiersMRN HR-BX001-SYN-TD; SSN (made up) 000-01-7724
Document date1996-03-10
AuthorCeleste Moreau, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-week Parkinson's disease follow-up, seen the same day by movement disorders neurology. [S]

History of Present Illness

Mr. Ali is a 54-year-old man with young-onset Parkinson's disease, diagnosed twelve years ago, who returns four weeks after his first visit and is seen by movement disorders neurology on the same day. Slowness of movement is still his main limitation: buttoning, handwriting, and getting out of low chairs take him longer, and he feels the slowness most in the late morning and late afternoon. The right-hand tremor is mild and settles when he uses the hand. People still have trouble hearing him in a crowd. He takes carbidopa-levodopa 25/100 mg one tablet three times a day, often with meals, and has noticed no wearing-off before doses, no involuntary movements, and no lightheadedness on standing. He has had no falls or near falls. He sleeps well, has no dream enactment, and has no hallucinations or new urges to gamble, shop, or eat. [S]

ElementDetail
Motor symptomsSlowness the main limitation; mild right-hand rest tremor; no freezing
Motor complicationsNo wearing-off or dyskinesia
FallsNone
SpeechSoft voice; hard to hear in crowds
Non-motorNo lightheadedness, hallucinations, impulse-control problems, constipation, or sleep problems

Review of Systems

SystemResultFinding
CardiovascularNegativeNo lightheadedness on standing or fainting
GastrointestinalNegativeNo nausea, constipation, or trouble swallowing
NeurologicalPositiveSlowness of movement and mild right-hand tremor; no freezing or involuntary movements
PsychiatricNegativeMood good; no hallucinations or impulse-control problems
Ears, nose, mouth, and throatPositiveSoft voice, hard to hear in noisy places; no drooling

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Carbidopa-levodopa 25/100 mg oral tablet, one tablet by mouth three times dailyOne tablet by mouth three times daily, at about 7 a.m., noon, and 5 p.m.Oral route1984-10-01 to 1996-03-10completedS
Carbidopa-levodopa 25/100 mg oral tablet, one and a half tablets by mouth three times daily, 30 minutes before mealsOne and a half tablets (levodopa 150 mg) by mouth three times daily, 30 minutes before mealsOral route1996-03-10activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1996-03-10Body height191cmS
1996-03-10Body weight102kgS
1996-03-10Body mass index (BMI) [Ratio]28kg/m2S
1996-03-10Systolic blood pressure126mm[Hg]S
1996-03-10Diastolic blood pressure78mm[Hg]S
1996-03-10Heart rate70/minS
1996-03-10Respiratory rate14/minS
1996-03-10Body temperature36.6CelS
1996-03-10Oxygen saturation in Arterial blood by Pulse oximetry98%S

Physical Exam

Vital signs recorded on 1996-03-10; see the Vital Signs section. [S]

SystemFinding
GeneralAlert, humorous, and engaged; reduced facial expression
CardiovascularRegular rhythm at 70 per minute. Blood pressure 128/80 mmHg after 5 minutes supine and 122/78 mmHg after 3 minutes standing, without symptoms; no orthostatic hypotension
NeurologicalIn the on state about two hours after a dose: MDS-UPDRS Part III 30, Hoehn and Yahr stage 2.5. Bilateral bradykinesia and rigidity, worse on the right; mild right-hand rest tremor; soft, monotone speech; no dyskinesia
GaitShort steps with reduced arm swing; recovers unaided after three steps on the pull test; Timed Up and Go 13 seconds

Problems

ProblemClinical statusVerificationCodeProvenance
Parkinson's disease, young onset (diagnosed at 42), Hoehn and Yahr stage 2.5, without dyskinesia or motor fluctuationsactiveconfirmed G20.A1S — Synthetic modern coding of the publicly disclosed diagnosis; the stage and the absence of motor complications are synthetic.
Hypokinetic dysarthria with soft speech due to Parkinson's diseaseactiveconfirmed R47.1S — Synthetic modern coding of the publicly reported speech difficulty; the severity is synthetic.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationMDS-UPDRS Parts III and IV and Hoehn and Yahr stageEvery visitCompleted todayPart III 30 in the on state; Hoehn and Yahr 2.5; Part IV: no dyskinesia, wearing-off, or on-off
ExaminationOrthostatic blood pressure, supine and after 3 minutes standingEvery visit while on dopaminergic treatmentCompleted today128/80 mmHg supine and 122/78 mmHg at 3 minutes standing; no orthostatic hypotension
Medication safetyDopaminergic regimen review for wearing-off, dyskinesia, and on-offEvery visitCompleted todayNo motor complications; bradykinesia limits daily tasks, so levodopa is increased to 150 mg three times daily before meals
Medication safetyAvoidance of dopamine-blocking drugsEvery visitCompleted todayNo antipsychotic, metoclopramide, or prochlorperazine; ondansetron is the antiemetic of choice if one is ever needed
Medication safetyMedication side effects and adherenceEvery visitCompleted todayNo nausea or sleepiness; no missed doses, though doses are often taken with meals
ExaminationFall query and fall-risk assessment (Timed Up and Go, pull test)Every visitCompleted todayNo falls or near falls; Timed Up and Go 13 seconds; recovers after three steps on the pull test
SurveyPsychotic symptoms (hallucinations, delusions)Every visitCompleted todayNone
SurveyImpulse-control screen (QUIP-RS)Every visit; mandatory on a dopamine agonistCompleted todayNegative; not on a dopamine agonist
Self-managementExercise counseling: aerobic, resistance, and balance, at least 150 minutes a weekEvery visitCompleted todayWalks 30 minutes most days; physical therapy will add balance and strength work toward 150 minutes a week
Self-managementAdvance care planning and goals of careAt diagnosis and at least yearlyDuePlanned for the preventive visit in the autumn
ExaminationDiagnosis review against the MDS clinical diagnostic criteriaYearlyCompleted todayMovement disorders neurology confirms clinically established Parkinson's disease: bradykinesia with rest tremor and rigidity, a clear response to levodopa, and no red flags
SurveyCognitive screen (MoCA)At least yearlyUp to dateMoCA 27 of 30 four weeks ago
SurveyDepression, anxiety, and apathy (PHQ-9)At least yearlyUp to datePHQ-9 3 four weeks ago
SurveySleep: REM sleep behavior disorder questionnaire, Epworth Sleepiness Scale, insomnia, restless legsAt least yearlyUp to dateNegative REM sleep behavior disorder screen and Epworth score 6 four weeks ago
SurveyAutonomic symptoms: constipation, urinary, sexual, sweating, droolingAt least yearlyUp to dateNo autonomic symptoms four weeks ago
SurveySwallowing screen (EAT-10)At least yearlyUp to dateEAT-10 score 2 four weeks ago, below the threshold of 3
ExaminationSpeech and voice loudnessYearly; speech therapy for speech changeReferredSoft, monotone speech; four-week LSVT LOUD course starts next week
ReferralPhysical, occupational, and speech therapyAt diagnosis, then reassessed yearlyReferredPhysical therapy for gait and balance and speech therapy arranged; occupational therapy not needed now because he is independent in daily activities
ReferralMovement disorders neurology consultationAt diagnosis, then yearly or with a changeCompleted todaySeen today for diagnosis review, levodopa adjustment, and rehabilitation planning
LaboratoryGenetic testing with counselingOnce, offered to every person with Parkinson's diseaseDueOffered by neurology today with counseling; he will decide at the yearly neurology review
ExaminationDental and oral examinationEvery 6 monthsDueNo dental visit on record; to be arranged
ExaminationDriving safetyYearly or with a motor or cognitive changeUp to dateDrives short local trips in daylight; MoCA 27 and no daytime sleepiness four weeks ago; review yearly or with any change
Self-managementVaccination status (influenza, pneumococcal, zoster, COVID-19, Tdap)Yearly, per the CDC scheduleDueInfluenza vaccine given last autumn; pneumococcal, zoster, COVID-19, and Tdap to be reviewed at the preventive visit
LaboratoryRoutine laboratory monitoringNot required for Parkinson's disease surveillanceNot indicatedThe CMID monograph calls for no routine laboratory tests; baseline blood count, chemistry, vitamin B12, and TSH were normal at the first visit
ImagingBrain MRIIf atypical parkinsonism features appearNot indicatedNo atypical features; neurology agrees no imaging is needed
ImagingPolysomnography for REM sleep behavior disorderIf REM sleep behavior disorder treatment is consideredNot indicatedNo dream enactment
Medication safetyAGS Beers Criteria medication reviewYearly from age 65Not indicatedHe is 54
ExaminationDeep brain stimulation programming reviewEvery 6 to 12 months after implantationNot indicatedNo deep brain stimulator

Goal progress:

Guideline basis: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee (2021); MDS clinical diagnostic criteria for Parkinson's disease (2015); The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension (2017); CMID: Clinical Monitoring Intelligence Database, Parkinson's disease monograph (2026)

Follow-up: Three-month Parkinson's disease review, with supine and standing blood pressure after the levodopa increase. Speech therapy starts next week and physical therapy within two weeks. Next scheduled visit 1996-06-09: three-month Parkinson's disease review after the levodopa increase and speech therapy. [S]